Strs Ohio Enanta Pharmaceuticals Inc Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Strs Ohio holds 12,100 shares of ENTA stock, worth $75,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,100

Previous 12,100 -0.0%

Holding current value

$75,988

Previous $156,000 19.87%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$11.43 - $17.02 $44,577 - $66,378	-3,900 Reduced 24.38%	12,100 $156,000
Q1 2024 May 13, 2024	SELL	$10.08 - $17.46 $27,216 - $47,142	-2,700 Reduced 14.44%	16,000 $279,000
Q4 2023 Jan 30, 2024	BUY	$8.18 - $10.78 $26,176 - $34,496	3,200 Added 20.65%	18,700 $175,000
Q2 2023 Jul 31, 2023	BUY	$20.68 - $39.85 $24,816 - $47,820	1,200 Added 8.39%	15,500 $331,000
Q1 2023 Aug 02, 2023	SELL	$38.82 - $54.59 $46,584 - $65,508	-1,200 Reduced 7.74%	14,300 $578,000
Q3 2022 Oct 27, 2022	SELL	$48.29 - $71.27 $28,974 - $42,762	-600 Reduced 4.03%	14,300 $741,000
Q2 2022 Jul 25, 2022	BUY	$38.13 - $76.93 $30,504 - $61,544	800 Added 5.67%	14,900 $704,000
Q4 2021 Jan 24, 2022	BUY	$60.19 - $97.37 $222,703 - $360,269	3,700 Added 35.58%	14,100 $1.05 Million
Q3 2021 Oct 22, 2021	SELL	$41.02 - $58.65 $188,692 - $269,790	-4,600 Reduced 30.67%	10,400 $590,000
Q2 2021 Jul 26, 2021	BUY	$43.76 - $53.11 $61,264 - $74,354	1,400 Added 10.29%	15,000 $660,000
Q2 2020 Jul 23, 2020	BUY	$46.37 - $57.58 $51,007 - $63,338	1,100 Added 8.8%	13,600 $682,000
Q4 2019 Jan 24, 2020	BUY	$57.95 - $66.61 $40,565 - $46,627	700 Added 5.93%	12,500 $772,000
Q3 2019 Oct 21, 2019	BUY	$60.08 - $88.17 $48,064 - $70,536	800 Added 7.27%	11,800 $708,000
Q2 2019 Jul 25, 2019	BUY	$81.3 - $97.35 $821,130 - $983,235	10,100 Added 1122.22%	11,000 $928,000
Q4 2018 Jan 23, 2019	SELL	$65.41 - $84.65 $699,887 - $905,755	-10,700 Reduced 92.24%	900 $63,000
Q3 2018 Oct 19, 2018	BUY	$85.46 - $126.37 $68,368 - $101,096	800 Added 7.41%	11,600 $991,000
Q2 2018 Aug 06, 2018	SELL	$81.85 - $120.51 $73,665 - $108,459	-900 Reduced 7.69%	10,800 $1.25 Million
Q1 2018 Apr 20, 2018	SELL	$57.91 - $92.15 $295,341 - $469,965	-5,100 Reduced 30.36%	11,700 $946,000
Q4 2017 Jan 23, 2018	SELL	$45.65 - $59.37 $31,955 - $41,559	-700 Reduced 4.0%	16,800 $985,000
Q3 2017 Oct 23, 2017	BUY	$37.91 - $46.8 $663,424 - $819,000	17,500	17,500 $819,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $130M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account